Optimized GENE TARGET framework characterizes barriers to therapeutic development for monogenic neurodevelopmental disorders
Authors:
- Raymond Belanger DelogeRDRaymond Belanger Deloge
- Abigail SvedenASAbigail Sveden
- Zoë FrazierZFZoë Frazier
- Hailey OsikaHOHailey Osika
- Charlotte ByrneCBCharlotte Byrne
- Jillian O’TOoleJOJillian O’TOole
- Muhammed BayraktutanMBMuhammed Bayraktutan
- Kira A. DiesKDKira A. Dies
- Stephanie J. BrewsterSBStephanie J. Brewster
- Pilar TrellesPTPilar Trelles
- Morgan E. RyanMRMorgan E. Ryan
- Bo ZhangBZBo Zhang
Open Access
- 17 October 2026
- journal article
- Published by Elsevier in Molecular Therapy Advances
- Vol. 34 (4)
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Tuning the polyethylene glycol-lipid anchor length of lipid nanoparticles to enhance brain-targeted siRNA deliveryActa Biomaterialia, 2025
- A Genomic Sequencing Approach to Newborn Mass Screening and Its OpportunitiesJAMA Network Open, 2025
- Lipid Nanoparticles Enhance mRNA Delivery to the Central Nervous System Upon Intrathecal InjectionAdvanced Materials, 2025
- Prenatal gene editing for neurodevelopmental diseases: Ethical considerationsThe American Journal of Human Genetics, 2025
- Expanded Newborn Screening Using Genome Sequencing for Early Actionable ConditionsJAMA, 2025
- Gene replacement therapies for inherited disorders of neurotransmission: Current progress in succinic semialdehyde dehydrogenase deficiencyJournal of Inherited Metabolic Disease, 2024
- CDKL5 deficiency in adult glutamatergic neurons alters synaptic activity and causes spontaneous seizures via TrkB signalingCell Reports, 2023
- INFRAFRONTIER: mouse model resources for modelling human diseasesMammalian Genome, 2023
- Systemic administration of novel engineered AAV capsids facilitates enhanced transgene expression in the macaque CNSMed, 2022
- A cross-disorder dosage sensitivity map of the human genomeCell, 2022